Advances in Oto-Rhino-Laryngology 2002-01-01

Clinical experience with caroverine in inner ear diseases.

Klaus Ehrenberger

Index: Adv. Otorhinolaryngol. 59 , 156-62, (2002)

Full Text: HTML

Abstract

The glutamatergic synapses between the cochlear inner hair cells and their afferent neurons seem to be mostly involved in the pathophysiology of the cochlea. Glutamatergic neurotoxicity is characterized by a mitochondrial overproduction of free oxygen radicals damaging lipid membranes and DNA structures of the postsynaptic neuron followed by the clinical symptoms of hearing loss and tinnitus. In preclinical tests, quinoxaline derivatives antagonized these deleterious consequences of too high an amount of free radicals. Therefore the clinically available quinoxaline dione caroverine provides a new approach to a successful treatment of tinnitus, sudden hearing loss and speech discrimination disorders in presbyacusis. The results of corresponding clinical trials are presented.

Related Compounds

  • Caroverine HCl

Related Articles:

Possible contribution of pannexin channel to ATP-induced currents in vitro in vasopressin neurons isolated from the rat supraoptic nucleus

2011-06-07

[Brain Res. 1394 , 71-8, (2011)]

[Drug therapy for disturbances of smelling].

2004-02-01

[Laryngorhinootologie. 83(2) , 124-34, (2004)]

[Therapy of olfactory loss].

2003-08-01

[Laryngorhinootologie. 82(8) , 552-4, (2003)]

Caroverine, a multifunctional drug with antioxidant functions.

2003-01-01

[Biofactors 19(1-2) , 79-85, (2003)]

Caroverine inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats.

2003-10-02

[Neurosci. Lett. 349(2) , 91-4, (2003)]

More Articles...